Billionaire Profile
Anna Maria Braun
Global Rank
#2423

Image: Public domain | via Wikimedia Commons

Anna Maria Braun

CEO, B. Braun Melsungen AG
DE
Real-Time Net Worth
$1.5B
As of December 2025
Age
46
Source
Medical technology
Industry
healthcare
Citizenship
DE

Biography

Anna Maria Braun is a prominent German business executive and attorney, currently serving as the CEO of B. Braun Melsungen AG, a leading medical device and pharmaceutical company. Born in Melsungen, Germany, on July 3, 1979, she represents the sixth generation of her family to lead the company. Anna Maria holds a Master of Laws degree from Georgetown University and joined B. Braun in 2009, quickly rising through the ranks. Her current estimated net worth is $1.5 billion, stemming from her ownership of 10% of B. Braun Melsungen AG. She is also a member of the board of the Bertelsmann Stiftung since September 2024, demonstrating her commitment to broader societal contributions beyond her successful career. Under her leadership, B. Braun has continued to expand its global operations and develop innovative products.

Wealth Over Time

In-Depth Profile

Early Life and Education

Anna Maria Braun was born in Melsungen, Germany, on July 3, 1979. She is the daughter of Ludwig Georg Braun, the former CEO of B. Braun Melsungen AG. Anna Maria attended high school in England and later pursued higher education at Georgetown University in Washington, D.C., where she earned a Master of Laws degree.

Rise to Success

Anna Maria Braun began her career at B. Braun in 2009, quickly ascending through various roles. In 2013, she was appointed head of the subsidiary B. Braun Medical Industries in Malaysia. Her responsibilities expanded in 2016 when she became a member of the board of B. Braun Melsungen AG, overseeing operations in the Asia-Pacific region. She was appointed CEO of B. Braun in April 2019, becoming the sixth generation of her family to lead the company.

Key Business Strategies

As CEO, Anna Maria Braun has focused on innovation, sustainability, and global expansion. She has spearheaded the adoption of digital health solutions and initiatives to reduce the company's environmental footprint. Her leadership has solidified B. Braun's position as a leader in the healthcare sector, marked by strategic expansions and product launches.

Philanthropy

Beyond her corporate responsibilities, Anna Maria Braun is committed to philanthropy. She is a member of the Board of Trustees of the Robert Koch Foundation, a German non-profit organization that promotes medical research. She is also a member of the board of the B. Braun Foundation, which works in education, science and public health in the field of human medicine, as well as a member of the board of the Bertelsmann Stiftung.

Career Milestones

2009

Joined B. Braun

Began her career at the family-owned medical technology company, B. Braun Melsungen AG.

2013

Head of B. Braun Medical Industries

Appointed head of the subsidiary B. Braun Medical Industries in Malaysia.

2016

Board Member B. Braun Melsungen AG

Became a member of the board, responsible for Asia-Pacific operations.

2019

CEO of B. Braun Melsungen AG

Appointed CEO, leading the company and representing the sixth generation of her family to do so.

2024

Member of the Board of Trustees of Bertelsmann Stiftung

Appointed to the board in September 2024, contributing to the development of the foundation.

Philanthropy & Social Impact

Medical Research

Robert Koch Foundation

Undisclosed

Member of the Board of Trustees

Education, Science, and Public Health

B. Braun Foundation

Undisclosed

Works in education, science and public health in the field of human medicine

Business Philosophy & Leadership

Notable Quotes

"I value the work of the Bertelsmann Foundation very much and look forward to being able to provide impetus for a dynamic and constructive development of our country as a trustee."

Leadership Principles

Innovation

Spearheading the adoption of digital health solutions and fostering new product development.

Sustainability

Focusing on reducing the company's environmental footprint and promoting sustainable practices.

Global Expansion

Driving strategic expansions and product launches to solidify B. Braun's position in the global healthcare market.